Non-Invasive Biomarkers of NASH

The following publication discusses the latest research regarding the Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis (NASH).  Nature Medicine originally published this article, coauthored by ERG’s Vice President of Clinical Pharmacology Services Clay Dehn, on February 10th, 2022.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

STUDIES ARE ENROLLING NOW!

DEPRESSION

If you or someone you know is affected by depression, upcoming clinical trials may be an option. Learn more today!

SMOKING

Are you a current smoker? You may qualify for a clinical trial evaluating various heated tobacco products.